GRCE Grace Therapeutics, Inc.

NASDAQ
$1.71

Grace Therapeutics, Inc. (GRCE) Insider Activity

What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.

Insider signal Bullish Insiders bought more than they sold over this window — uncommon at any size.
Cluster activity 1 buyer in the last 30 days 2 buyers in the last 90 days 0 sellers in the last 90 days
Insiders buying
1
7 transactions
Insiders selling
0
0 transactions
Purchases
$233.9K
132,913 shares
Sales
$0
0 shares
Net activity
$233.9K
purchases less sales

Where they traded

Buy Sell Dot area is proportional to transaction value.

Last open-market purchase: November 18, 2026 , by Opaleye Management Inc. .

Recent open-market activity

Date Insider Role Action Shares Price Value Held after
Opaleye Management Inc. 10% Owner Buy 2,974 $1.73 $5.1K 3,102,904
Opaleye Management Inc. 10% Owner Buy 29,207 $1.72 $50.3K 3,099,930
Opaleye Management Inc. 10% Owner Buy 15,879 $1.76 $28.0K 3,070,723
Opaleye Management Inc. 10% Owner Buy 3,087 $1.77 $5.5K 3,054,853
Opaleye Management Inc. 10% Owner Buy 5,027 $1.80 $9.1K 3,051,766
Opaleye Management Inc. 10% Owner Buy 10,328 $1.79 $18.5K 3,046,739
Opaleye Management Inc. 10% Owner Buy 66,411 $1.77 $117.4K 3,036,411

Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.